Century Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
PHILADELPHIA, Sept. 26, 2022 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ:IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that Lalo Flores, Ph.D., Chief Executive Officer, will participate in a panel titled “Next Generation Gene Editing” at Chardan’s 6th Annual Genetic Medicines Conference on Monday, October 3, 2022, at 10:30 AM ET.
Related news for (IPSC)
- Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
- Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
- Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
- Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
- Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update